NCT01630135 - Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis | Biotech Hunter

Enrollment

261

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG

Fluticasone furoate

55 mcg/day, intranasal, 2 weeks

DRUG

Placebo

Placebo, intranasal, 2 weeks

Trial Locations (22)

261-0004

GSK Investigational Site, Chiba

270-0034

GSK Investigational Site, Chiba

272-0143

GSK Investigational Site, Chiba

277-0882

GSK Investigational Site, Chiba

279-0012

GSK Investigational Site, Chiba

501-3247

GSK Investigational Site, Gifu

001-0923

GSK Investigational Site, Hokkaido

061-1133

GSK Investigational Site, Hokkaido

062-0034

GSK Investigational Site, Hokkaido

222-0011

GSK Investigational Site, Kanagawa

222-0031

GSK Investigational Site, Kanagawa

232-0056

GSK Investigational Site, Kanagawa

333-0861

GSK Investigational Site, Saitama

350-1205

GSK Investigational Site, Saitama

354-0018

GSK Investigational Site, Saitama